Achelios Therapeutics’ lead reformulation product, TOPOFEN™, pairs its proprietary ACHETOGEL™ delivery technology with the proven NSAID ketoprofen. In pre-clinical and early-stage clinical studies, they have shown TOPOFEN™ (ketoprofen) to provide superior tissue penetration compared to other topical formulations currently on the market.

Biotechnology

Achelios Therapeutics

Achelios Therapeutics' headquarters in Chapel Hill, NC, United States

The Scientific and Clinical Operations team at Achelios Therapeutics focuses on advancing the development and clinical testing of the company's lead product, TOPOFEN™. This team leverages their expertise to oversee pre-clinical and clinical studies, ensuring robust tissue penetration and effectiveness of TOPOFEN™ while adhering to regulatory standards and scientific rigor.

Scientific and Clinical Operations

The Leadership Team at Achelios Therapeutics is responsible for setting the strategic direction and vision of the company. This team, composed of key executives including the President & CEO, CTO, and CMO, collaborates on research and development, clinical operations, and commercialization strategies to drive the success of innovative products like TOPOFEN™. Their collective expertise ensures effective management of resources, regulatory compliance, and market positioning to enhance the company's growth and impact in therapeutic delivery.

��

People (3)

Jobs (0)

Other teams

Leadership Team

��������

People (3)

Jobs (0)

Other teams

Leadership Team

��